Matinas Biopharma Holdings, Inc. (NYSE: MTNB) was downgraded by analysts at Alliance Global Partners from a "strong-buy" rating to a "hold" rating.
Matinas Biopharma Holdings, Inc. (NYSE: MTNB) was downgraded by analysts at Maxim Group from a "strong-buy" rating to a "hold" rating.
Matinas Biopharma Holdings, Inc. (NYSE: MTNB) was downgraded by analysts at Alliance Global Partners from a "strong-buy" rating to a "hold" rating.
Matinas Biopharma Holdings, Inc. (NYSE: MTNB) was downgraded by analysts at Maxim Group from a "strong-buy" rating to a "hold" rating.
Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction